Quarterly report pursuant to Section 13 or 15(d)

Note 15 - Financial Information About the Parent, the Issuer and the Guarantors (Detail) - Condensed Consolidating Statement Of Cash Flows

v2.4.0.6
Note 15 - Financial Information About the Parent, the Issuer and the Guarantors (Detail) - Condensed Consolidating Statement Of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Net cash provided by (used in) operating activities $ 44,445 $ 27,833
Cash flows from investing activities:    
Capital expenditures 16,545 19,836
Acquisitions 598 520
Proceeds from the disposal of property, plant and equipment 3,226 1,792
Change in restricted cash and investments 14 (981)
Purchase of marketable securities 17,547 3,290
Proceeds from the sale of marketable securities 7,990 4,675
Other (1,333) (773)
Net cash provided by (used in) investing activities (22,155) (15,425)
Cash flows from financing activities:    
Payments on long-term debt 187 12,145
Dividends paid 19,617 6,046
Purchases and other retirements of company stock   847
Other 1,423 500
Net cash provided by (used in) financing activities (18,381) (18,538)
Effect of exchange rate changes on cash 15 741
Net decrease in cash and cash equivalents 3,924 (5,389)
Cash & cash equivalents at beginning of period 79,721 78,519
Cash & cash equivalents at end of period 83,645 73,130
Parent Company [Member]
   
Net cash provided by (used in) operating activities 18,360 6,668
Cash flows from financing activities:    
Dividends paid (19,617) (6,046)
Purchases and other retirements of company stock   (847)
Other 1,257 225
Net cash provided by (used in) financing activities (18,360) (6,668)
Subsidiary Issuer [Member]
   
Net cash provided by (used in) operating activities 12,214 2,161
Cash flows from investing activities:    
Capital expenditures (1,115) (1,592)
Proceeds from the disposal of property, plant and equipment 51  
Change in restricted cash and investments (14) 981
Purchase of marketable securities (17,547) (3,290)
Proceeds from the sale of marketable securities 7,990 4,675
Other 783 262
Net cash provided by (used in) investing activities (9,852) 1,036
Cash flows from financing activities:    
Payments on long-term debt   (11,918)
Other 166  
Net cash provided by (used in) financing activities 166 (11,918)
Net decrease in cash and cash equivalents 2,528 (8,721)
Cash & cash equivalents at beginning of period 64,946 69,763
Cash & cash equivalents at end of period 67,474 61,042
Guarantor Subsidiaries [Member]
   
Net cash provided by (used in) operating activities 10,950 16,667
Cash flows from investing activities:    
Capital expenditures (13,165) (16,833)
Acquisitions (598) (520)
Proceeds from the disposal of property, plant and equipment 3,175 1,792
Other 550 511
Net cash provided by (used in) investing activities (10,038) (15,050)
Cash flows from financing activities:    
Payments on long-term debt (187) (227)
Other   275
Net cash provided by (used in) financing activities (187) 48
Net decrease in cash and cash equivalents 725 1,665
Cash & cash equivalents at beginning of period 12,276 7,716
Cash & cash equivalents at end of period 13,001 9,381
Non-Guarantor Subsidiaries [Member]
   
Net cash provided by (used in) operating activities 2,921 2,337
Cash flows from investing activities:    
Capital expenditures (2,265) (1,411)
Net cash provided by (used in) investing activities (2,265) (1,411)
Cash flows from financing activities:    
Effect of exchange rate changes on cash 15 741
Net decrease in cash and cash equivalents 671 1,667
Cash & cash equivalents at beginning of period 2,499 1,040
Cash & cash equivalents at end of period 3,170 2,707
Consolidated Entities [Member]
   
Net cash provided by (used in) operating activities 44,445 27,833
Cash flows from investing activities:    
Capital expenditures (16,545) (19,836)
Acquisitions (598) (520)
Proceeds from the disposal of property, plant and equipment 3,226 1,792
Change in restricted cash and investments (14) 981
Purchase of marketable securities (17,547) (3,290)
Proceeds from the sale of marketable securities 7,990 4,675
Other 1,333 773
Net cash provided by (used in) investing activities (22,155) (15,425)
Cash flows from financing activities:    
Payments on long-term debt (187) (12,145)
Dividends paid (19,617) (6,046)
Purchases and other retirements of company stock   (847)
Other 1,423 500
Net cash provided by (used in) financing activities (18,381) (18,538)
Effect of exchange rate changes on cash 15 741
Net decrease in cash and cash equivalents 3,924 (5,389)
Cash & cash equivalents at beginning of period 79,721 78,519
Cash & cash equivalents at end of period $ 83,645 $ 73,130